Cargando…
Diltiazem inhibits breast cancer metastasis via mediating growth differentiation factor 15 and epithelial-mesenchymal transition
Migration and metastasis commonly happen to triple-negative breast cancer (TNBC) patients with advanced diseases. In many studies, it has been suggested that epithelial-mesenchymal transition (EMT) is one of the key mechanisms triggering cancer metastasis. Accumulating evidence has proven that calci...
Autores principales: | Chen, Yen-Chang, Wu, Chen-Teng, Chen, Jia-Hong, Tsai, Cheng-Fang, Wu, Chen-Yun, Chang, Pei-Chun, Yeh, Wei-Lan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9376069/ https://www.ncbi.nlm.nih.gov/pubmed/35963873 http://dx.doi.org/10.1038/s41389-022-00423-5 |
Ejemplares similares
-
Sciellin mediates mesenchymal-to-epithelial transition in colorectal cancer hepatic metastasis
por: Chou, Chuan-Kai, et al.
Publicado: (2016) -
Isoliquiritigenin Inhibits Ovarian Cancer Metastasis by Reversing Epithelial-to-Mesenchymal Transition
por: Chen, Chen, et al.
Publicado: (2019) -
Regorafenib inhibits epithelial-mesenchymal transition and suppresses cholangiocarcinoma metastasis via YAP1-AREG axis
por: Chang, Yu-Chan, et al.
Publicado: (2022) -
Goosecoid Promotes the Metastasis of Hepatocellular Carcinoma by Modulating the Epithelial-Mesenchymal Transition
por: Xue, Tong-Chun, et al.
Publicado: (2014) -
Epithelial-Mesenchymal Transition with Malignant Transformation Leading Multiple Metastasis from Disseminated Peritoneal Leiomyomatosis
por: Chiu, Hsiao-Chen, et al.
Publicado: (2018)